New York 2023-2024 Regular Session

New York Senate Bill S09728

Introduced
5/23/24  

Caption

Establishes a wound care kit and xylazine test strip distribution program to supply wound care kits designed for the treatment of injection-related wounds and skin and soft tissue infections, and xylazine test strips, to individuals with a substance use disorder or who are otherwise at risk of drug use, free of charge; prohibits facilities from collecting personally identifying information on such individuals; prohibits police from targeting individuals receiving wound care kits or xylazine test strips under such program.

Companion Bills

No companion bills found.

Previously Filed As

NY S02446

Establishes a wound care kit and xylazine test strip distribution program to supply wound care kits designed for the treatment of injection-related wounds and skin and soft tissue infections, and xylazine test strips, to individuals with a substance use disorder or who are otherwise at risk of drug use, free of charge; prohibits facilities from collecting personally identifying information on such individuals; prohibits police from targeting individuals receiving wound care kits or xylazine test strips under such program.

NY A05374

Establishes a wound care kit and xylazine test strip distribution program to supply wound care kits designed for the treatment of injection-related wounds and skin and soft tissue infections, and xylazine test strips, to individuals with a substance use disorder or who are otherwise at risk of drug use, free of charge; prohibits facilities from collecting personally identifying information on such individuals; prohibits police from targeting individuals receiving wound care kits or xylazine test strips under such program.

NY SB1502

Controlled substances: xylazine.

NY SB6

Controlled substances: xylazine.

NY SB875

Excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.

NY AB950

Excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.

NY SCR36

Requesting The Department Of The Attorney General To Conduct A Study To Determine If Xylazine Testing Strips Should Be Excluded From The State's Definition Of Drug Paraphernalia.

NY SR24

Requesting The Department Of The Attorney General To Conduct A Study To Determine If Xylazine Testing Strips Should Be Excluded From The State's Definition Of Drug Paraphernalia.

NY A5488

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

NY HCR194

Requesting The Department Of Law Enforcement To Conduct A Study To Determine If Xylazine Testing Strips Should Be Excluded From The State's Definition Of Drug Paraphernalia.

Similar Bills

No similar bills found.